Mild Lafora disease: Clinical, neurophysiologic, and genetic findings

Edoardo Ferlazzo, Laura Canafoglia, Roberto Michelucci, Antonio Gambardella, Elena Gennaro, Elena Pasini, Patrizia Riguzzi, Rosaria Plasmati, Lilia Volpi, Angelo Labate, Sara Gasparini, Flavio Villani, Marina Casazza, Maurizio Viri, Federico Zara, Berge A. Minassian, Julie Turnbull, Jose M. Serratosa, Rosa Guerrero-Lõpez, Silvana FranceschettiUmberto Aguglia

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We report clinical, neurophysiologic, and genetic features of an Italian series of patients with Lafora disease (LD) to identify distinguishing features of those with a slowly progressive course. Twenty-three patients with LD (17 female; 6 male) were recruited. Mean age (± SD) at the disease onset was 14.5 ± 3.9 years and mean follow-up duration was 13.2 ± 8.0 years. NHLRC1 mutations were detected in 18 patients; EPM2A mutations were identified in 5. Patients who maintained >10 years gait autonomy were labeled as "mild" and were compared with the remaining LD patients with a typical course. Six of 23 patients were mild and presented significantly delay in the age at onset, lower neurologic disability score at 4 years after the onset, less severe seizure phenotype, lower probability of showing both photoparoxysmal response on electroencephalography (EEG) and giant somatosensory evoked potentials, as compared to patients with typical LD. However, in both mild and typical LD patients, EEG showed disorganization of background activity and frequent epileptiform abnormalities. Mild LD patients had NHLRC1 mutations and five of six carried homozygous or compound heterozygous D146N mutation. This mutation was found in none of the patients with typical LD. The occurrence of specific NHLRC1 mutations in patients with mild LD should be taken into account in clinical practice for appropriate management and counseling.

Original languageEnglish
Pages (from-to)e129-e133
JournalEpilepsia
Volume55
Issue number12
DOIs
Publication statusPublished - Dec 1 2014

Fingerprint

Lafora Disease
Mutation
Electroencephalography
Somatosensory Evoked Potentials
Practice Management
Gait
Age of Onset
Nervous System

Keywords

  • Dementia
  • EEG
  • Mild
  • Progressive myoclonus epilepsy
  • Slowly progressive

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Ferlazzo, E., Canafoglia, L., Michelucci, R., Gambardella, A., Gennaro, E., Pasini, E., ... Aguglia, U. (2014). Mild Lafora disease: Clinical, neurophysiologic, and genetic findings. Epilepsia, 55(12), e129-e133. https://doi.org/10.1111/epi.12806

Mild Lafora disease : Clinical, neurophysiologic, and genetic findings. / Ferlazzo, Edoardo; Canafoglia, Laura; Michelucci, Roberto; Gambardella, Antonio; Gennaro, Elena; Pasini, Elena; Riguzzi, Patrizia; Plasmati, Rosaria; Volpi, Lilia; Labate, Angelo; Gasparini, Sara; Villani, Flavio; Casazza, Marina; Viri, Maurizio; Zara, Federico; Minassian, Berge A.; Turnbull, Julie; Serratosa, Jose M.; Guerrero-Lõpez, Rosa; Franceschetti, Silvana; Aguglia, Umberto.

In: Epilepsia, Vol. 55, No. 12, 01.12.2014, p. e129-e133.

Research output: Contribution to journalArticle

Ferlazzo, E, Canafoglia, L, Michelucci, R, Gambardella, A, Gennaro, E, Pasini, E, Riguzzi, P, Plasmati, R, Volpi, L, Labate, A, Gasparini, S, Villani, F, Casazza, M, Viri, M, Zara, F, Minassian, BA, Turnbull, J, Serratosa, JM, Guerrero-Lõpez, R, Franceschetti, S & Aguglia, U 2014, 'Mild Lafora disease: Clinical, neurophysiologic, and genetic findings', Epilepsia, vol. 55, no. 12, pp. e129-e133. https://doi.org/10.1111/epi.12806
Ferlazzo, Edoardo ; Canafoglia, Laura ; Michelucci, Roberto ; Gambardella, Antonio ; Gennaro, Elena ; Pasini, Elena ; Riguzzi, Patrizia ; Plasmati, Rosaria ; Volpi, Lilia ; Labate, Angelo ; Gasparini, Sara ; Villani, Flavio ; Casazza, Marina ; Viri, Maurizio ; Zara, Federico ; Minassian, Berge A. ; Turnbull, Julie ; Serratosa, Jose M. ; Guerrero-Lõpez, Rosa ; Franceschetti, Silvana ; Aguglia, Umberto. / Mild Lafora disease : Clinical, neurophysiologic, and genetic findings. In: Epilepsia. 2014 ; Vol. 55, No. 12. pp. e129-e133.
@article{058e37cb172847d9bbbc4ae612ce30d7,
title = "Mild Lafora disease: Clinical, neurophysiologic, and genetic findings",
abstract = "We report clinical, neurophysiologic, and genetic features of an Italian series of patients with Lafora disease (LD) to identify distinguishing features of those with a slowly progressive course. Twenty-three patients with LD (17 female; 6 male) were recruited. Mean age (± SD) at the disease onset was 14.5 ± 3.9 years and mean follow-up duration was 13.2 ± 8.0 years. NHLRC1 mutations were detected in 18 patients; EPM2A mutations were identified in 5. Patients who maintained >10 years gait autonomy were labeled as {"}mild{"} and were compared with the remaining LD patients with a typical course. Six of 23 patients were mild and presented significantly delay in the age at onset, lower neurologic disability score at 4 years after the onset, less severe seizure phenotype, lower probability of showing both photoparoxysmal response on electroencephalography (EEG) and giant somatosensory evoked potentials, as compared to patients with typical LD. However, in both mild and typical LD patients, EEG showed disorganization of background activity and frequent epileptiform abnormalities. Mild LD patients had NHLRC1 mutations and five of six carried homozygous or compound heterozygous D146N mutation. This mutation was found in none of the patients with typical LD. The occurrence of specific NHLRC1 mutations in patients with mild LD should be taken into account in clinical practice for appropriate management and counseling.",
keywords = "Dementia, EEG, Mild, Progressive myoclonus epilepsy, Slowly progressive",
author = "Edoardo Ferlazzo and Laura Canafoglia and Roberto Michelucci and Antonio Gambardella and Elena Gennaro and Elena Pasini and Patrizia Riguzzi and Rosaria Plasmati and Lilia Volpi and Angelo Labate and Sara Gasparini and Flavio Villani and Marina Casazza and Maurizio Viri and Federico Zara and Minassian, {Berge A.} and Julie Turnbull and Serratosa, {Jose M.} and Rosa Guerrero-L{\~o}pez and Silvana Franceschetti and Umberto Aguglia",
year = "2014",
month = "12",
day = "1",
doi = "10.1111/epi.12806",
language = "English",
volume = "55",
pages = "e129--e133",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Blackwell Publishing Inc.",
number = "12",

}

TY - JOUR

T1 - Mild Lafora disease

T2 - Clinical, neurophysiologic, and genetic findings

AU - Ferlazzo, Edoardo

AU - Canafoglia, Laura

AU - Michelucci, Roberto

AU - Gambardella, Antonio

AU - Gennaro, Elena

AU - Pasini, Elena

AU - Riguzzi, Patrizia

AU - Plasmati, Rosaria

AU - Volpi, Lilia

AU - Labate, Angelo

AU - Gasparini, Sara

AU - Villani, Flavio

AU - Casazza, Marina

AU - Viri, Maurizio

AU - Zara, Federico

AU - Minassian, Berge A.

AU - Turnbull, Julie

AU - Serratosa, Jose M.

AU - Guerrero-Lõpez, Rosa

AU - Franceschetti, Silvana

AU - Aguglia, Umberto

PY - 2014/12/1

Y1 - 2014/12/1

N2 - We report clinical, neurophysiologic, and genetic features of an Italian series of patients with Lafora disease (LD) to identify distinguishing features of those with a slowly progressive course. Twenty-three patients with LD (17 female; 6 male) were recruited. Mean age (± SD) at the disease onset was 14.5 ± 3.9 years and mean follow-up duration was 13.2 ± 8.0 years. NHLRC1 mutations were detected in 18 patients; EPM2A mutations were identified in 5. Patients who maintained >10 years gait autonomy were labeled as "mild" and were compared with the remaining LD patients with a typical course. Six of 23 patients were mild and presented significantly delay in the age at onset, lower neurologic disability score at 4 years after the onset, less severe seizure phenotype, lower probability of showing both photoparoxysmal response on electroencephalography (EEG) and giant somatosensory evoked potentials, as compared to patients with typical LD. However, in both mild and typical LD patients, EEG showed disorganization of background activity and frequent epileptiform abnormalities. Mild LD patients had NHLRC1 mutations and five of six carried homozygous or compound heterozygous D146N mutation. This mutation was found in none of the patients with typical LD. The occurrence of specific NHLRC1 mutations in patients with mild LD should be taken into account in clinical practice for appropriate management and counseling.

AB - We report clinical, neurophysiologic, and genetic features of an Italian series of patients with Lafora disease (LD) to identify distinguishing features of those with a slowly progressive course. Twenty-three patients with LD (17 female; 6 male) were recruited. Mean age (± SD) at the disease onset was 14.5 ± 3.9 years and mean follow-up duration was 13.2 ± 8.0 years. NHLRC1 mutations were detected in 18 patients; EPM2A mutations were identified in 5. Patients who maintained >10 years gait autonomy were labeled as "mild" and were compared with the remaining LD patients with a typical course. Six of 23 patients were mild and presented significantly delay in the age at onset, lower neurologic disability score at 4 years after the onset, less severe seizure phenotype, lower probability of showing both photoparoxysmal response on electroencephalography (EEG) and giant somatosensory evoked potentials, as compared to patients with typical LD. However, in both mild and typical LD patients, EEG showed disorganization of background activity and frequent epileptiform abnormalities. Mild LD patients had NHLRC1 mutations and five of six carried homozygous or compound heterozygous D146N mutation. This mutation was found in none of the patients with typical LD. The occurrence of specific NHLRC1 mutations in patients with mild LD should be taken into account in clinical practice for appropriate management and counseling.

KW - Dementia

KW - EEG

KW - Mild

KW - Progressive myoclonus epilepsy

KW - Slowly progressive

UR - http://www.scopus.com/inward/record.url?scp=84920183366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920183366&partnerID=8YFLogxK

U2 - 10.1111/epi.12806

DO - 10.1111/epi.12806

M3 - Article

C2 - 25270369

AN - SCOPUS:84920183366

VL - 55

SP - e129-e133

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 12

ER -